Adventures of PhRMA Intern!
Last week I reported on PhRMA's tardy response to my complaint about Sepracor's violation of PhRMA's DTC Guiding Principles (see "PhRMA's Response - PRwise, it Stinks!"). I also posted questions to...
The Marketing Mix Maze
An article entitled "The Marketing Maze" in a special marketing section of yesterday's Wall Street Journal presents a breakdown of US advertising expenditures for 2005. The source for this data...
DTC, Elections, and PhRMA
My post yesterday regarding PhRMA's response to my letter citing a violation of its DTC Guiding Principles by Sepracor (see "PhRMA's Response - PRwise, it Stinks!") generated a few comments.Laurie Bredenfoerder...
PhRMA’s Response – PRwise, it Stinks!
On May 3, 2006 I wrote to PhRMA's Office of Accountability complaining that Sepracor was "sneaking" in Lunesta "reminder ads" despite being a signatory to PhRMA's Guiding Principles for DTC Advertising...
Chantix: PR First, Launch & Ads to Follow
Continuing my study of PR (Public Relations) as a "stealth" pharma marketing tool, I read the book "The Fall of Advertising & The Rise of PR" by Al and Laura Ries...
PR Marketing: Mystery Wrapped in a Riddle
Yesterday's post, "Marketing Disguised as PR", generated some interesting counterpoints and comments from friends in the blogosphere and on the PHARMA-MKTING discussion forum. Seems that I have hit upon something worthy...
Marketing Disguised as PR
Public Relations (PR) is not just for managing a company's image and for damage control. It's also used as an adjunct to marketing products and sometimes the distinction is blurred.PR is...
AMA vs DTC: Spinmeisters at Work
The American Medical Association recently called for an FDA-mandated moratorium on direct-to-consumer (DTC) drug ads and left it up to the industry and FDA to work out the details; ie, how...
CME: Promotion vs Education
Pharmaceutical companies provide over half the financial support and funding for continuing medical education (CME) programs. In 2004, the industry spent over $1 Billion to support CME. This does not include...
Fat Acomplia?
Occasionally, I predict the next frontier in pharmaceutical marketing. Back in September, 2005, for example, I predicted that "sleep aid" DTC (direct-to-consumer) advertising would be the next BIG thing (see "Insomnia...
